Shenzhen, China

Huixing Yuan

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Hybio Pharmaceutical Co., Ltd.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Huixing Yuan. Retrieved from https://idiyas.com/inventor/huixing-yuan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Huixing Yuan: Innovator in Pharmaceutical Chemistry

Introduction

Huixing Yuan is a notable inventor based in Shenzhen, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of glatiramer acetate. His innovative methods have the potential to impact the treatment of various medical conditions.

Latest Patents

Huixing Yuan holds a patent for a method for preparing glatiramer acetate. The patent outlines a detailed process that includes dissolving specific N-carboxyanhydrides in a solvent, catalyzing the reaction, and purifying the final product through a series of steps. This method showcases his expertise in chemical synthesis and formulation.

Career Highlights

Yuan is currently associated with Hybio Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in enhancing the efficiency and effectiveness of pharmaceutical preparations.

Collaborations

He has collaborated with notable colleagues such as Guotao Li and Jian Hua Liu. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Huixing Yuan's contributions to pharmaceutical chemistry, particularly through his patent for glatiramer acetate, highlight his role as an innovator in the field. His work at Hybio Pharmaceutical Co., Ltd. and collaborations with esteemed colleagues further emphasize his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…